Join the club for FREE to access the whole archive and other member benefits.

LEAF interviews AgeX Therapeutics CEO Dr. Michael West

May only be a few years away from implementing induced tissue regeneration in humans

30-Sep-2019

Key points from article :

He founded AgeX Therapeutics, a daughter company of BioTime Inc, in 2017.

Working on making young cells for old people.

If able to replace cartilage, like replacing a tyre, it would stop the pain of osteoarthritis.

We now know how to make pluripotent stem cells so that the immune system would not reject them.

Age-related macular degeneration could be fixed by growing retinal pigment epithelial cells.

Injecting RPE cells will not cause teratomas.

HyStem matrix enables cells to be delivered into the body and reliably stay where required.

Mentioned in this article:

Click on resource name for more details.

AgeX Therapeutics

Biotechnology company focused on the development of novel therapeutics for age-related degenerative disease

Michael D. West

Dr Michael D West is the founder and CEO of AgeX Therapeutics

Topics mentioned on this page:
Rejuvenation, Stem Cells